A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)
Incyte Corporation
Incyte Corporation
City of Hope Medical Center
City of Hope Medical Center
Eisai Inc.
Rutgers, The State University of New Jersey
University of Nebraska
University of Nebraska
Columbia University
Bristol-Myers Squibb
Memorial Sloan Kettering Cancer Center
miRagen Therapeutics, Inc.
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
Galderma R&D
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Mayo Clinic
Mayo Clinic
Northwestern University
Barbara Ann Karmanos Cancer Institute
University of Texas Southwestern Medical Center
Northwestern University
National Institutes of Health Clinical Center (CC)
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Massachusetts General Hospital
Mayo Clinic
Alliance for Clinical Trials in Oncology
University of Rochester
Barbara Ann Karmanos Cancer Institute
City of Hope Medical Center
M.D. Anderson Cancer Center
Vanderbilt-Ingram Cancer Center
Altor BioScience
Vanderbilt-Ingram Cancer Center
M.D. Anderson Cancer Center
Northside Hospital, Inc.
Mayo Clinic